EMA consults on proposed update to process validation guideline for drug makers
This article was originally published in SRA
Executive Summary
The European Medicines Agency is seeking feedback on proposed updates1 to its process validation guideline for pharmaceutical manufacturers that are designed to bring the document in line with guidance from the International Conference on Harmonisation.